-
Zuberoa García-Alvarado joins as head of the healthcare and scientific business unit.
-
She has more than 15 years of experience in key account management and business development in regulated sectors.
-
RDT is expanding its sectors of activity in a phase of strategic growth.
RDT, a leading company in global and integrated engineering and technology solutions, announces the incorporation of Zuberoa García as the new Director of the Life Sciences business unit. This appointment is part of the company’s strategy in the life sciences industry, a key sector that is undergoing a rapid transformation.
Zuberoa has more than 15 years of experience. Prior to joining RDT, he held strategic roles in the sector where he is known for his involvement in pioneering projects with a high degree of innovation. Overseeing all commercial, business development and market access activities. He has played a decisive role in the management of strategic alliances.
In his new role, Zuberoa will be responsible for identifying and solving pharmaceutical and healthcare needs. He will also lead initiatives aimed at delivering innovative technology solutions designed to meet the needs of an evolving industry.
The pharmaceutical and healthcare industry faces significant challenges in improving operational efficiency and harnessing the potential of advanced technologies. Process automation plays a crucial role in increasing productivity, ensuring higher quality standards and optimising production times. Moreover, digital transformation is redefining industry dynamics by incorporating tools such as artificial intelligence, real-time data analytics and digital twins, which allow processes to be simulated, optimised and monitored with unprecedented accuracy. These innovations are accelerating the industry’s responsiveness to market demands and positioning the companies that adopt them as leaders in a highly competitive environment.
These trends represent a great opportunity for companies like RDT, which offers comprehensive solutions capable of addressing the technological and industrial challenges of its customers. From the design of automated systems to the implementation of disruptive technologies, RDT is positioned as a strategic partner for innovation in the pharmaceutical sector.
‘I am very excited to join RDT, a company that is committed to innovation and excellence in engineering and technology. The pharmaceutical industry faces great challenges, from process digitisation to sustainability, but also significant opportunities to make a real difference. I am convinced that RDT has the potential to lead this change and I look forward to contributing to the success of this mission’, said Zuberoa regarding his new role and joining RDT.
Iñaki Ulizar, Director of Strategy and Technology, commented: ‘Zuberoa is an exceptional professional who brings a combination of experience, strategic vision and a client-focused approach. Her arrival represents an important step in our strategy to consolidate our position as a benchmark in the pharmaceutical sector’.
About RDT
RDT is an innovative corporation whose field of activity is the development of advanced engineering projects, participating in projects with a high technological component where it provides flexibility in the outsourcing strategy of large companies. RDT’s mission is to provide engineering solutions that give our clients a competitive advantage based on efficiency, flexibility and reliability. Its main purpose: that engineers enjoy engineering.